Intergroupe Francophone De Cancerologie Thoracique

This study tests a drug called ivonescimab in 38 people with pleural mesothelioma whose cancer returned after standard treatments. The drug aims to slow or stop tumor growth by blocking blood vessel formation and reactivating the immune system. Participants receive the drug every…

This study tests whether the targeted drug tepotinib works better than standard treatments for people with advanced non-small cell lung cancer that has a specific MET gene change. About 133 adults who have already tried at least one prior treatment will be randomly assigned to re…